60
Participants
Start Date
November 30, 2008
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
Aflibercept
Administered in combination with the other two interventions via intravenous infusion.
Pemetrexed
Administered in combination with the other two interventions via intravenous infusion.
Cisplatin
Administered in combination with the other two interventions via intravenous infusion.
Montefiore Medical Center, The Bronx
Roswell Park Cancer Institute, Buffalo
Erie Regional Cancer Center, Erie
Schiffler Cancer Center - Medical Oncology Division, Wheeling
Presbyterian Hospital Center for Cancer Research, Charlotte
Palm Beach Institute of Hematology and Oncology, Boynton Beach
Kentucky Cancer Clinic, Hazard
Edward Hines Jr. VA Medical Center, Hines
University of Arkansas for Medical Science, Little Rock
Arizona Cancer Institute, LLC, Tucson
UNM Cancer Clinic, Albuquerque
Stanford University Medical Center, Stanford
Sidney Kimmel Comprehensive Cancer Center, Baltimore
Dartmouth-Hitchcock Medical Center, Lebanon
Princess Margaret Hospital, Toronto
Collaborators (1)
Sanofi
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY